Both show up on “best antioxidant supplement” lists, both come from fruit, and both are marketed with similar promises around heart health and healthy aging. So it’s natural to wonder which one is actually stronger.
The honest answer is that “stronger” depends on how you measure it. A compound can look powerful in a test tube and behave very differently once it passes through your gut and liver.
This article compares pomegranate extract and resveratrol on three things that matter more than marketing: how they behave in the body, what clinical trials actually show, and who might reasonably prefer one over the other.
Medical Overview
Pomegranate extract is rich in ellagitannins, mainly punicalagins, while resveratrol is a single stilbene compound found in grapes, berries, and peanuts. Both are polyphenols with antioxidant activity in laboratory settings.
No head-to-head human trial has directly compared the two, so any claim that one is definitively “stronger” goes beyond the available evidence. What can be compared is how each one is absorbed and how each has performed in randomized trials on outcomes like blood pressure.
Anyone taking prescription medication, especially blood pressure drugs or blood thinners, should check with a healthcare provider before starting either supplement.
What Each One Actually Is
Pomegranate extract is a mix of compounds. Punicalagins are the headline ingredient, and they’re concentrated mostly in the peel rather than the juicy arils (Determination of Punicalagins Content, Metal Chelating, and Antioxidant Properties of Pomegranate Peels and Seeds, PMC).
Resveratrol is a single, isolated molecule. That makes it easier to standardize and dose, but it also means you’re relying on one compound rather than a broader polyphenol profile.
Why “Antioxidant Strength” in a Lab Doesn’t Settle It
Most direct comparisons of antioxidant power come from in vitro assays, which measure how well a compound neutralizes free radicals in a test tube. These tests are useful for screening, but they don’t account for what happens after you swallow a capsule.
In the body, what matters is how much of the active compound reaches tissues, in what form, and for how long. That’s where the two ingredients look quite different from what lab numbers alone would suggest.
Bioavailability: Both Have a Catch
Resveratrol is well absorbed but barely survives intact. In a human study using radiolabeled resveratrol, at least 70% of an oral dose was absorbed, yet only trace amounts of unchanged resveratrol appeared in plasma because it was rapidly converted into sulfate and glucuronide conjugates (Walle et al., 2004, Drug Metabolism and Disposition). Later reviews put its systemic bioavailability at roughly 0.5%, which is one reason clinical results haven’t always matched lab findings (Resveratrol and Its Human Metabolites, PMC).
Pomegranate has a similar story with a different twist. Ellagic acid is absorbed quickly and cleared quickly, peaking around one hour after ingestion (Seeram et al., 2006, Journal of Nutrition), while gut bacteria convert ellagitannins into urolithins that peak 24 to 48 hours later (Urolithins, Intestinal Microbial Metabolites, Journal of Agricultural and Food Chemistry).
In both cases, the compounds circulating in your blood are largely metabolites rather than the original molecule on the label. That’s why the benefits of each are better judged by clinical outcomes than by antioxidant assay scores.
Clinical Evidence: Blood Pressure as a Test Case
Blood pressure is one of the few outcomes with enough randomized trials on both ingredients to compare fairly.
For pomegranate, an 8-week placebo-controlled trial found a meaningful reduction in diastolic blood pressure (Stockton et al., 2017, Journal of Nutritional Science), and a 12-week trial in adults aged 55 to 70 reported lower systolic pressure and reduced inflammatory markers (Nutrients, 2025). Effects were modest but relatively consistent across trials.
For resveratrol, results are more mixed. A meta-analysis of six trials found no significant overall effect on blood pressure, with a systolic reduction appearing only in the subgroup taking 150 mg per day or more (Liu et al., 2015, Clinical Nutrition). A larger meta-analysis of 28 trials in people with metabolic syndrome and related conditions found no effect on systolic or diastolic pressure, although it did report improved flow-mediated dilation, a marker of blood vessel function (Akbari et al., 2019, High Blood Pressure & Cardiovascular Prevention).
An umbrella review of resveratrol trials did report blood-pressure-lowering effects in people with type 2 diabetes, supported by high-certainty evidence (umbrella review, Nutrition Journal). So resveratrol may work better for some populations than others, rather than universally failing.
Side-by-Side Snapshot
| Pomegranate Extract | Resveratrol | |
|---|---|---|
| Key compounds | Punicalagins, ellagic acid | Trans-resveratrol |
| What reaches the blood | Ellagic acid, urolithins | Mostly sulfate and glucuronide conjugates |
| Blood pressure evidence | Modest, fairly consistent across small RCTs | Mixed; dose- and population-dependent |
| Head-to-head human data | None | None |
Who Might Prefer Which
If your main interest is general polyphenol intake with a whole-fruit-derived, multi-compound profile, pomegranate extract is a reasonable fit, particularly with the blood pressure trial data behind it.
If you’re specifically interested in resveratrol, the evidence is more nuanced, and the form matters, since newer formulations aim to improve its poor bioavailability.
Some people take both, but there’s no clinical data on combining them, so that’s a conversation to have with a doctor or pharmacist rather than a default stack.
FAQs
There’s no direct human comparison, so it can’t be stated definitively. Lab assays measure something different from what happens in the body, where both compounds are heavily metabolized after absorption.
Pomegranate has more consistent, if modest, results across small trials. Resveratrol’s results are mixed, with effects showing up mainly at higher doses or in specific groups such as people with type 2 diabetes.
It’s absorbed well in the gut but rapidly converted to conjugates in the intestine and liver, so very little unchanged resveratrol reaches the bloodstream. That’s the main reason lab results haven’t always carried over into clinical trials.
No clinical trials have tested the combination, so there’s no evidence-based guidance on it. Talk to a healthcare provider first, particularly if you take blood pressure medication or blood thinners.
Neither has strong human trial data for skin outcomes from oral supplementation. Most of the interest comes from laboratory research on antioxidant pathways.
Both are generally well tolerated, but pomegranate has documented interactions with certain medications, covered in our guide to pomegranate supplement side effects and interactions. Anyone on prescription medication should check with a doctor before starting either one.
Final Thoughts
Neither compound wins on lab antioxidant scores alone, because those scores don’t predict how the body handles them. Judged by randomized trial data on blood pressure, pomegranate extract currently has the steadier, if modest, track record.
Resveratrol remains an active research area, particularly for people with type 2 diabetes, but its low bioavailability makes results depend heavily on dose and formulation.
If you’re leaning toward pomegranate, our current picks are in Best Pomegranate Supplements. For a closer look at what pomegranate research does and doesn’t show, see Pomegranate Extract Benefits: What Science Actually Says.
Anyone managing high blood pressure, diabetes, or taking prescription medication should talk to a healthcare provider before choosing between these supplements, rather than relying on one as a substitute for treatment.